Pfizer Inc. and BioNTech SE on Wednesday said their COVID-19 vaccine was safe and effective and produced a robust antibody response in 12 to 15-year-olds, following a trial of 2,260 adolescents.
There were 18 cases of COVID-19 in the group that got a placebo shot and none in the group that got the vaccine, resulting in 100 per cent efficacy in preventing the disease caused by the novel coronavirus, they said.
Reggie Cecchini reports on what this means going forward for the Pfizer vaccine and what's next in the effort to combat the pandemic.
For more info, please go to https://globalnews.ca/news/7730444/pfizer-covid-vaccine-safe-effective-adolescents-trial/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #COVID19 #coronavirus
There were 18 cases of COVID-19 in the group that got a placebo shot and none in the group that got the vaccine, resulting in 100 per cent efficacy in preventing the disease caused by the novel coronavirus, they said.
Reggie Cecchini reports on what this means going forward for the Pfizer vaccine and what's next in the effort to combat the pandemic.
For more info, please go to https://globalnews.ca/news/7730444/pfizer-covid-vaccine-safe-effective-adolescents-trial/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #COVID19 #coronavirus
- Category
- U.S. & Canada
- Tags
- Pfizer, COVID-19, Coronavirus Vaccine
Sign in or sign up to post comments.
Be the first to comment